<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02567487</url>
  </required_header>
  <id_info>
    <org_study_id>931893045140401</org_study_id>
    <nct_id>NCT02567487</nct_id>
  </id_info>
  <brief_title>TAP Block With Two Different Doses of Levobupivacaine</brief_title>
  <official_title>Comparison of TAP Block With Two Different Doses of Levobupivacaine for Postoperative Pain Management in Pediatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current study is to investigate the effects of two different doses of
      levobupivacaine in TAP (transversus abdominus plane) block for postoperative management. For
      this purpose we planned to include 50 children aged between 2 and 12 that will undergo
      unilateral inguinal surgery.

      The doses that will be used in the study were within usual dose limits which is stated in
      prospectus of the study drug.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fifty children undergoing TAP block were randomly divided into two groups as levobupivacaine
      0.25% 0.5 ml/kg and levobupivacaine 0.25% 0.25 ml/kg. Postoperative pain was evaluated with
      observational pain scale and modified pediatric objective pain scale.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">July 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative VAS score &lt;4 at postoperative 24 hours</measure>
    <time_frame>Postoperative first 24 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Group Levobupivacaine high volume</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TAP block with levobupivacaine 0.25% of 0.5 ml/kg under general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Levobupivacaine low volume</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TAP block with levobupivacaine 0.25% of 0.25 ml/kg under general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levobupivacaine</intervention_name>
    <description>Transversus abdominis plane block with levobupivacaine</description>
    <arm_group_label>Group Levobupivacaine high volume</arm_group_label>
    <arm_group_label>Group Levobupivacaine low volume</arm_group_label>
    <other_name>Chirocaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Volunteers planned to undergo unilateral inguinal surgery under TAP (ilioinguinal and
             iliohypogastric block) and general anesthesia

          -  Aged between 2 and 12

        Exclusion Criteria:

          -  Patients with coagulation dysfunction

          -  Patients with chronic pain

          -  Patients having infection at the site of intervention

          -  Patients with a history of allergy

          -  Patients having chronic diseases (hepatic dysfunction, renal failure)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neslihan Alkis</last_name>
    <role>Study Director</role>
    <affiliation>Ankara University Medical Faculty</affiliation>
  </overall_official>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 17, 2015</study_first_submitted>
  <study_first_submitted_qc>October 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 5, 2015</study_first_posted>
  <last_update_submitted>October 2, 2015</last_update_submitted>
  <last_update_submitted_qc>October 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara University</investigator_affiliation>
    <investigator_full_name>Emel Uyar</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levobupivacaine</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

